Company Filing History:
Years Active: 1981
Title: James S. Cox: Innovator in Therapeutic Treatments
Introduction
James S. Cox is a notable inventor based in Zofingen, Switzerland. He has made significant contributions to the field of therapeutic treatments, particularly through his innovative work on xanthine oxidase inhibitors. His research has the potential to impact the treatment of uratic diathesis in warm-blooded animals, including humans.
Latest Patents
James S. Cox holds a patent for a therapeutic xanthine oxidase inhibitor composition. This composition contains as an active ingredient 3-dimethylamino-7-methyl-1,2-(n-propylmalonyl)-1,2-dihydro-1,2,4-benzotriazine dihydrate. The patent outlines a method for treating uratic diathesis by administering this xanthine oxidase inhibitor either orally or via injection, effectively inhibiting xanthine oxidase activity.
Career Highlights
Cox is associated with Siegfried Aktiengesellschaft, a company known for its focus on pharmaceutical development and manufacturing. His work at the company has allowed him to explore innovative solutions in therapeutic treatments, contributing to advancements in medical science.
Collaborations
James S. Cox has collaborated with notable colleagues, including Kurt Thiele and Johanna Fischer. These partnerships have fostered a collaborative environment that enhances the development of innovative therapeutic solutions.
Conclusion
James S. Cox's contributions to the field of therapeutic treatments through his patent on xanthine oxidase inhibitors exemplify the impact of innovation in medicine. His work continues to pave the way for advancements in the treatment of various conditions.